Tag: agios pharmaceuticals
January 1, 2019
An Investor’s Guide to Clinical Trials
Clinical trials can be one of the more challenging US Food and Drug Administration processes to understand, but grasping the... December 3, 2018
Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial
Agios Pharmaceuticals (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today presented... November 16, 2018
Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma
Agios Pharmaceuticals (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today presented... July 20, 2018
FDA Grants Approval of Agios’ Pharmaceuticals’ TIBSOVO®
Agios Pharmaceuticals (NASDAQ:AGIO) has announced that TIBSOVO was granted approval from the US Food and Drug Administration (FDA) for treatment... June 26, 2018